lifestyle.brightsfuture.com

Author: Abivax

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares

May 5, 2026
Abivax to Present Data on Obefazimod at Digestive Disease Week®

April 22, 2026
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

April 20, 2026
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

April 1, 2026